These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5623526)

  • 1. [Healing apparent 5 years after chemotherapy for cervix epidermoid carcinoma in advanced phase].
    Amalric R; Ayme Y; Desgeorge Y; Spitalier JM
    Mars Med; 1967; 104(12):1081-3. PubMed ID: 5623526
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
    Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.
    Slavik M; Muss H; Blessing JA
    Cancer Treat Rep; 1983 Feb; 67(2):195-6. PubMed ID: 6297730
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Roberts JA; Blessing JA; McGehee R; Beecham J; Homesley HD
    Cancer Treat Rep; 1987 Dec; 71(12):1295-6. PubMed ID: 3690541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the recording of cytostatic effects on organ cultures of squamous cell carcinoma of the uterine cervix].
    Ebeling K; Ruckhäberle KE; Bilek K
    Zentralbl Gynakol; 1977; 99(20):1249-59. PubMed ID: 595962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer.
    Nobeyama H; Sumi T; Misugi F; Okamoto E; Hattori K; Matsumoto Y; Yasui T; Honda K; Iwai K; Ishiko O
    Int J Mol Med; 2004 Jul; 14(1):101-5. PubMed ID: 15202023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-agent chemotherapy for recurrent carcinoma of the cervix.
    Freedman RS; Herson J; Wharton JT; Rutledge FN
    Cancer Clin Trials; 1980; 3(4):345-50. PubMed ID: 6775827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
    Brenner DE; Rosenshein NB; Dillon M; Jones HW; Forastiere A; Tipping S; Burnett LS; Greco FA; Wiernik PH
    Cancer Treat Rep; 1985 Apr; 69(4):457-8. PubMed ID: 3995514
    [No Abstract]   [Full Text] [Related]  

  • 10. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI; Blessing JA; Levenback C; Moore JL
    Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of disseminated squamous cell carcinoma of the cervix.
    Reed ML
    J Am Osteopath Assoc; 1971 Aug; 70(12):1331-2. PubMed ID: 5209204
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression.
    Benhaim Y; Pautier P; Bensaid C; Lhommé C; Haie-Meder C; Morice P
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):267-8. PubMed ID: 17157432
    [No Abstract]   [Full Text] [Related]  

  • 14. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
    Dunst J
    Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
    [No Abstract]   [Full Text] [Related]  

  • 15. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
    Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alkylating monochemotherapy in the treatment of carcinomas of the uterine cervix and endometrium in advanced phases].
    Alberini L; Perego C
    Minerva Ginecol; 1982; 34(1-2):99-104. PubMed ID: 7078831
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
    Kornovski Ia; Ianeva R; Gorchev G; Tsekov Kh; Uzunov S; Filev S
    Akush Ginekol (Sofiia); 2002; 41(4):39-44. PubMed ID: 12516261
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal therapy for relapsed carcinoma of the cervix after primary chemoradiation.
    Mano M; Kerr J
    J Clin Oncol; 2004 Dec; 22(24):5021-2; author reply 5022. PubMed ID: 15611523
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.
    Omura GA; Vélez-García E; Birch R
    Cancer Treat Rep; 1981; 65(9-10):901-3. PubMed ID: 7196801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.